A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/145 (2006.01) A61K 39/39 (2006.01)
Patent
CA 2628328
Influenza vaccines containing insoluble particulate adjuvants have been found to elicit an IgG response that is primarily a TH2 response (IgGl). This response can be shifted towards a THl response (IgG2a) by including immunopotentiators in the compositions. Thus the invention provides an immunogenic composition comprising: (i) an influenza virus antigen; (ii) an insoluble particulate adjuvant; and (iii) a immunopotentiator.
Il a été démontré que les vaccins Influenza contenant des adjuvants particulaires insolubles provoquent une réponse IgG qui est principalement une réponse TH2 (IgG1). Cette réponse peut être modifiée en réponse TH1 (IgG2a) par ajout d'immunopotentiateurs dans les compositions. L'invention propose ainsi une composition immunogène qui comprend : (i) un antigène de virus influenza ; (ii) un adjuvant particulaire insoluble ; et (iii) un immunopotentiateur.
Del Guidice Guiseppe
O'hagan Derek
Rappuoli Rino
Borden Ladner Gervais Llp
Novartis Vaccines And Diagnostics S.r.l.
LandOfFree
Influenza vaccines including combinations of particulate... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Influenza vaccines including combinations of particulate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Influenza vaccines including combinations of particulate... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1865009